NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
NATURES SUNSHINE PRODUCTS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$12.55−0.09 (-0.71%)
Close on Oct 19, 2026
- Market cap
- $230.13M
- P/E (TTM)
- 12.4
- Dividend yield
- –
Share price
−$1.63 (−11.50%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
NATURES SUNSHINE PRODUCTS INC grew revenue 6.8% to $492.02M over the twelve months to Jun 30, 2026. Operating income rose 44.6% to $29.32M, moving the operating margin from 4.4% to 6.0%. Free cash flow was $18.09M, down 19.1% from a year earlier.
Revenue
$492.02M
+6.8% vs. a year earlier
Operating income
$29.32M
+44.6% vs. a year earlier
Free cash flow
$18.09M
-19.1% vs. a year earlier
EPS, diluted
$1.01
+36.5% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $230.13M
- P/E ratio
- 12.4
- Price to sales
- 0.47
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 7.86%
Fundamentals
- Revenue
- $492.02M
- Net income
- $18.10M
- EPS, diluted
- $1.01
- Free cash flow
- $18.09M
- Diluted shares
- 18M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$492.02M+6.8% YoY
Gross profit
$359.98M+8.8% YoY
Operating income
$29.32M+44.6% YoY
Net income
$18.10M+28.3% YoY
EPS, diluted
$1.01+36.5% YoY
Free cash flow
$18.09M-19.1% YoY
Reported periodTrailing twelve months